Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search

Cardiovascular Pharmacology

Citations 71-80 of 640 total displayed.

Past content (since Jan 1999):

Editorial Commentary
Hyperkalemia Risk in Chronic Kidney Disease. Deterrent to the Use of Aldosterone Receptor Antagonism or Not
Domenic A. Sica
Hypertension published March 23, 2009, doi:10.1161/HYPERTENSIONAHA.108.128017 [Abstract]  

Scientific Contributions
Mechanisms of Impaired Potassium Handling With Dual Renin-Angiotensin-Aldosterone Blockade in Chronic Kidney Disease
Richard A. Preston, David Afshartous, Dyal Garg, Sergio Medrano, Alberto B. Alonso, and Rolando Rodriguez
Hypertension published March 23, 2009, doi:10.1161/HYPERTENSIONAHA.108.125252 [Abstract]  

Scientific Contributions
Hemodynamic and Cardiac Effects of Chronic Eprosartan and Moxonidine Therapy in Stroke-Prone Spontaneously Hypertensive Rats
Suhayla Mukaddam-Daher, Ahmed Menaouar, Pierre-Alexandre Paquette, Marek Jankowski, Jolanta Gutkowska, Marc-Antoine Gillis, Yan-Fen Shi, Angelo Calderone, and Jean-Claude Tardif
Hypertension published March 9, 2009, doi:10.1161/HYPERTENSIONAHA.108.126524 [Abstract]  

Original Articles
Continued Improvement in Hypertension Management in England: Results From the Health Survey for England 2006
Emanuela Falaschetti, Moushumi Chaudhury, Jennifer Mindell, and Neil Poulter
Hypertension 2009;53:480-486; published online before print as doi:10.1161/HYPERTENSIONAHA.108.125617 [Abstract] [Full text]  

Editorial Commentary
Combined L-/T-Type Calcium Channel Blockers. Ready for Prime Time
Wei Ge and Jun Ren
Hypertension published February 23, 2009, doi:10.1161/HYPERTENSIONAHA.108.127548 [Abstract]  

Scientific Contributions
Heterogeneity of L- and T-Channels in the Vasculature. Rationale for the Efficacy of Combined L- and T-Blockade
Christine J. Ball, David P. Wilson, Stuart P. Turner, David A. Saint, and John F. Beltrame
Hypertension published February 23, 2009, doi:10.1161/HYPERTENSIONAHA.108.125831 [Abstract]  

Scientific Contributions
Characteristics and Outcomes of Revascularized Patients With Hypertension. An International Verapamil SR-Trandolapril Substudy
Scott J. Denardo, Franz H. Messerli, Efrain Gaxiola, Juan M. Aranda, Jr, Rhonda M. Cooper-DeHoff, Eileen M. Handberg, Yan Gong, Annette Champion, Qian Zhou, and Carl J. Pepine
Hypertension published February 23, 2009, doi:10.1161/HYPERTENSIONAHA.108.111542 [Abstract]  

Scientific Contributions
Atorvastatin Restores Endothelial Function in Offspring of Protein-Restricted Rats in a Cholesterol-Independent Manner
Christopher Torrens, Christopher J. Kelsall, Laura A. Hopkins, Frederick W. Anthony, Nick P. Curzen, and Mark A. Hanson
Hypertension published February 16, 2009, doi:10.1161/HYPERTENSIONAHA.108.122820 [Abstract]  

Scientific Contributions
Continued Improvement in Hypertension Management in England. Results From the Health Survey for England 2006
Emanuela Falaschetti, Moushumi Chaudhury, Jennifer Mindell, and Neil Poulter
Hypertension published February 9, 2009, doi:10.1161/HYPERTENSIONAHA.108.125617 [Abstract]  

Original Articles
Impact of Treatment on Myocardial Lysyl Oxidase Expression and Collagen Cross-Linking in Patients With Heart Failure
Begoña López, Ramón Querejeta, Arantxa González, Javier Beaumont, Mariano Larman, and Javier Díez
Hypertension 2009;53:236-242; published online before print as doi:10.1161/HYPERTENSIONAHA.108.125278 [Abstract] [Full text]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64

* Subspecialty Collections Home

* Show  Cardiovascular Pharmacology
 collections from other journals.

* Related collections:
 Treatment
 Ablation/ICD/surgery
 Behavioral/psychosocial - treatment
 Cardiovascular Pharmacology
 Catheter-based coronary and valvular interventions: other
 Catheter-based coronary interventions: stents
 Compliance/Adherence
 CPR and emergency cardiac care
 Exercise/exercise testing/rehabilitation
 Pacemaker
 Primary prevention
 Restenosis
 Secondary prevention
 Other Treatment